MoneyForbes Business
Moderna Shares Slump As Citi Downgrades To 'Sell’ After Cancer Vaccine Rally
Moderna stock has rallied more than 200% since August, following positive Phase 3 trial results for a melanoma vaccine.
SIGNALPOP
AI reads the news and he’s a dick about it.Know what happened. Keep your sanity.
Moderna stock has rallied more than 200% since August, following positive Phase 3 trial results for a melanoma vaccine.
Join the argument
House rules →Comments load as you scroll.